(Q37310486)

19 August 2017

1 reference

title

Therapeutic drug monitoring of phenytoin in critically ill patients (English)

1 reference

19 August 2017

0 references

1 reference

Sandrina L von Winckelmann

series ordinal

1

1 reference

19 August 2017

Isabel Spriet

series ordinal

2

1 reference

19 August 2017

Ludo Willems

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

28

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

1391-1400

1 reference

Clinical Pharmacokinetics of Phenytoin

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Phenytoin intoxication in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Therapeutic drug monitoring of old and newer anti-epileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Phenytoin toxicity: an easily missed cause of cerebellar syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Pharmacokinetics of drugs used in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Pharmacokinetics and pharmacodynamics in the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

The importance of drug interactions in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Phenytoin and enteral feedings: does evidence support an interaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinical utility of free drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Changes in plasma protein binding have little clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Comment: unbound drug concentration versus unbound drug fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Optimizing therapy of seizures in neurosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

21 January 2018

Phenytoin auto-induction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Plasma concentrations of unbound phenytoin in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Changes in plasma phenytoin level following craniotomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Interpatient and intrapatient variability in phenytoin protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Serum Concentrations of Free Diphenylhydantoin and their Relationship To Clinical Intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Measurement and analysis of unbound drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Therapeutic drug monitoring in saliva. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Synergistic effect of valproate coadministration and hypoalbuminemia on the serum-free phenytoin concentration in patients with severe motor and intellectual disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Therapeutic drug monitoring--antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Drugs pharmacokinetics in ICU patients: consequences of hypoalbuminemia upon drugs monitoring and dosing scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Should we routinely measure free plasma phenytoin concentration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

Clinical response in epilepsy in relation to total and free serum levels of phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.11.1391

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.11.1391

1 reference

19 August 2017

1 reference